SCHEMBL6136898

SCHEMBL6136898

NC(=O)C1(CSc2ncccn2)CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.40
HTT P42858 1/20 0.40
TSHR P16473 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA6 P23280 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA13 Q8N1Q1 2/20 0.35
ALDH1A1 P00352 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 2/20 0.33
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15961562 0.75 HSD17B10 (0.36) KMT2AKDM4EHTTSMN1; SMN2HSD17B10
SCHEMBL13977919 0.73 HSD17B10 (0.37) KMT2AKDM4EHTTSMN1; SMN2HPGD
SCHEMBL28013237 0.71 RAB9A (0.43) KMT2AHTTALDH1A1SMN1; SMN2HPGD
Quinoline SCHEMBL28013835 0.70 P2RY14 (0.41) KMT2AKDM4EHTTTSHRALDH1A1
SCHEMBL13977727 0.69 HTT (0.37) KMT2AKDM4EHTTALDH1A1SMN1; SMN2
SCHEMBL23881997 0.69 GAA (0.47) KMT2AKDM4ETSHRALDH1A1SMN1; SMN2
SCHEMBL28013817 0.68 MTNR1A (0.43) KMT2ACA1CA2ALDH1A1GAA
SCHEMBL4896827 0.67 KMT2A (0.38) KMT2AKDM4EHTTTSHRALDH1A1
SCHEMBL13977924 0.67 HTT (0.35) KMT2AKDM4EHTTALDH1A1SMN1; SMN2
SCHEMBL1327770 0.66 KMT2A (0.61) KMT2AHTTTSHRCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1446115-A4 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS MERCK FROSST CANADA INC (CA) 2005-02-02 EP disclosed
EP-1446115-A2 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS Merck Frosst Canada & Co. (CA) 2004-08-18 EP disclosed
WO-2003041649-A2 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS MERCK FROSST CANADA & CO. (CA) 2003-05-22 WO disclosed